SEC Company Response from CervoMed Inc. (CRVO) (CIK 0001053691) (CRVO) — Jan 17, 2018
CervoMed Inc. (CRVO) (CIK 0001053691)
Date: Jan. 17, 2018 · CIK: 0001053691 · Accession: 0001437749-18-000721
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222203
Letter
Re: Diffusion Pharmaceuticals Inc.
dffn20180116b_corresp.htm
January 17, 2018
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Registration Statement on Form S-1 (Registration No. 333-222203) -
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“Wainwright”), as managing underwriter for the referenced offering, hereby concurs in the request by Diffusion Pharmaceuticals Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Wednesday, January 17, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP 1 filename1.htm dffn20180116b_corresp.htm January 17, 2018 VIA FACSIMILE AND EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Re: Diffusion Pharmaceuticals Inc. Registration Statement on Form S-1 (Registration No. 333-222203) - Concurrence in Acceleration Request Ladies and Gentlemen: H.C. Wainwright & Co., LLC (“Wainwright”), as managing underwriter for the referenced offering, hereby concurs in the request by Diffusion Pharmaceuticals Inc. that the effective date of the above-referenced registration statement be accelerated to 5:00 P.M. Eastern Time on Wednesday, January 17, 2018, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act in connection with this offering. Very truly yours, H.C. WAINWRIGHT & CO., LLC By: /s/ Mark W. Viklund Name: Mark W. Viklund Title: Chief Executive Officer